⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATRA News
Atara Biotherapeutics, Inc
Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
ATRA
Deadline Alert: Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
ATRA
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ATRA
Pomerantz LLP Announces Securities Class Action Litigation Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA
accessnewswire.com
ATRA
Pomerantz LLP Announces The Filing of a Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
Pomerantz LLP Announces Securities Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
ATRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 Ready to Announce with Confidence?
newsfilecorp.com
ATRA
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ATRA
Pomerantz LLP Announces The Filing of a Class Action Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA